Company / Total Assets
Monte Rosa Therapeutics, Inc. Total Assets History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$438.7M
FY2024
5-year range
$49.4M / $438.7M
FY2020-FY2024
Trend
+44.4%
vs FY2023
Sector context
#151 of 214
Health Care
What the data says
At $439M, Monte Rosa Therapeutics, Inc.'s total assets ranks #151 of 214 in the Health Care sector. Total Assets returned to growth in FY2024 after 2 years of decline, reaching $439M.
Based on SEC 10-K filings.
$439M in FY2024 with a 3-year CAGR of +6.2%.
Improved from $342M to $439M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +6.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#151 of 214 in Health CareTop 71% of 214This company $438.7M Sector average $7.5B
▼
-94.1% below sector average
Key checks
Key Insights
- 3-year CAGR of +6.2%, indicating consistent growth.
- In FY2024, total assets increased 44.4% year-over-year.
- Ranks #151 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $438.7M | +44.4% |
| FY2023 | $303.8M | -11.3% |
| FY2022 | $342.4M | -6.5% |
| FY2021 | $366.3M | +641.9% |
| FY2020 | $49.4M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026